Skip to main content

GOLDMAN SACHS GROUP INC

Position in VIR — Vir Biotechnology, Inc.

CIK 886982 NEW YORK, NY

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$29,122,033
+$19,661,543 QoQ
Shares Held
3,250,227
+107.2% QoQ
Ownership
1.93%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,298,042,919 across 365 Biotechnology names. VIR ranks #75 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VIR

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,122,033 3,250,227
2025-12-31 $9,460,490 1,568,904
2025-09-30 $8,689,488 1,521,802
2025-06-30 $6,502,295 1,290,138
2025-03-31 $4,812,527 742,674
2024-12-31 $3,795,733 517,130
2024-09-30 $6,236,794 832,683
2024-06-30 $6,966,910 782,799
2024-03-31 $9,140,723 902,342
2023-12-31 $5,812,234 577,757
2023-09-30 $3,768,744 402,214
2023-06-30 $11,968,236 487,902
2023-03-31 $9,210,428 395,807
2022-12-31 $15,620,243 617,157
2022-09-30 $13,279,716 688,782
2022-06-30 $11,947,466 469,080
2022-03-31 $15,888,529 617,750
2021-12-31 $23,337,583 557,382
2021-09-30 $26,812,453 616,095
2021-06-30 $24,559,406 519,446
2021-03-31 $51,226,009 999,142
2020-12-31 $14,788,799 552,233
2020-09-30 $13,916,385 405,371
2020-06-30 $3,295,503 80,437
2020-03-31 $1,842,526 53,765